Form 8-K - Current report:
SEC Accession No. 0001193125-24-038108
Filing Date
2024-02-16
Accepted
2024-02-16 08:31:02
Documents
14
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d775782d8k.htm   iXBRL 8-K 24966
  Complete submission text file 0001193125-24-038108.txt   147174

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20240213.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20240213_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20240213_pre.xml EX-101.PRE 11271
16 EXTRACTED XBRL INSTANCE DOCUMENT d775782d8k_htm.xml XML 3670
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 24645869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)